DLA
CEMI

Douglas Lane & Associates’s Chembio diagnostics, Inc. CEMI Stock Holding History

Douglas Lane & Associates’s Portfolio CEMI Stock Details CEMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-14,055
Closed -$86K – 224
2019
Q2 		$86K Hold
14,055
– – ﹤0.01% 212
2019
Q1 		$78K Hold
14,055
– – ﹤0.01% 212
2018
Q4 		$80K Buy
+14,055
New +$104K ﹤0.01% 212

Other funds holding CEMI

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
RC
Roubaix Capital Denver, Colorado $214M AUM 32.43% 1-Year Est. Return

Douglas Lane & Associates's CEMI Position: Q3 2019 in Review

Douglas Lane & Associates sold out of Chembio diagnostics, Inc. (CEMI) in Q3 2019, closing a stake of 14,055 shares — an estimated $86K sold.

Douglas Lane & Associates first reported a position in CEMI in Q4 2018 and held it in 3 quarters. The position peaked at $86K in Q2 2019. 45 funds tracked by Wall St. Rank hold CEMI as of Q3 2019.

  • Douglas Lane & Associates reported no remaining Chembio diagnostics, Inc. position as of Q3 2019 after selling out during the quarter.
  • Douglas Lane & Associates sold 14,055 Chembio diagnostics, Inc. shares in Q3 2019, an estimated $86K.
  • Douglas Lane & Associates first reported a position in Chembio diagnostics, Inc. in Q4 2018 and held it in 3 quarters.
  • Douglas Lane & Associates's Chembio diagnostics, Inc. position peaked at $86K in Q2 2019.
  • 45 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q3 2019.

Based on Douglas Lane & Associates's 13F filing for Q3 2019, filed 16 Oct 2019.